Cargando…
Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection
INTRODUCTION: Two-stage revision remains the gold standard treatment for most chronically infected and complex total hip arthroplasty infections. To improve patient outcome and reduce complication rates, we have developed a novel custom-made articulating hip spacer technique and present our short-te...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596578/ https://www.ncbi.nlm.nih.gov/pubmed/34853867 http://dx.doi.org/10.1007/s00402-021-04274-4 |
_version_ | 1784815903280463872 |
---|---|
author | Lunz, Andre Omlor, Georg W. Schmidt, Gunter Moradi, Babak Lehner, Burkhard Streit, Marcus R. |
author_facet | Lunz, Andre Omlor, Georg W. Schmidt, Gunter Moradi, Babak Lehner, Burkhard Streit, Marcus R. |
author_sort | Lunz, Andre |
collection | PubMed |
description | INTRODUCTION: Two-stage revision remains the gold standard treatment for most chronically infected and complex total hip arthroplasty infections. To improve patient outcome and reduce complication rates, we have developed a novel custom-made articulating hip spacer technique and present our short-term results. MATERIALS AND METHODS: Between November 2017 and November 2019, 27 patients (mean age 70 years) underwent two-stage revision for periprosthetic joint infection of the hip using the articulating spacer design described here. We retrospectively analyzed spacer-related complications as well as rates for complication, infection control, and implant survivorship after final reimplantation. Furthermore, we prospectively collected patient-reported health-related quality of life (HRQoL) scores prior to spacer implantation, with the spacer and after reimplantation of the new prosthesis. RESULTS: An additional round of spacer exchange was performed in two patients (8.3%), persistent wound discharge was the reason in both cases. We had one (4.2%) spacer-related mechanical complication, a dislocation that was treated with closed reduction. After reimplantation, infection control was achieved in 96% with an implant survivorship of 92% after a mean follow-up time of 19 (range 7–32, SD 7.2) months. While the scores for VR-12 MCS, VAS hip pain and patient-reported overall satisfaction significantly improved after first stage surgery, the scores for WOMAC, UCLA and VR-12 PCS significantly improved after second stage surgery. CONCLUSIONS: Our two-stage approach for periprosthetic joint infection shows high infection eradication and implant survivorship rates at short-term follow-up. Spacer-related complication rates were low, and we achieved high patient satisfaction rates and low pain levels already during the spacer period. To further simplify comparison between different spacer designs, we propose a new hip spacer classification system. |
format | Online Article Text |
id | pubmed-9596578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-95965782022-10-27 Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection Lunz, Andre Omlor, Georg W. Schmidt, Gunter Moradi, Babak Lehner, Burkhard Streit, Marcus R. Arch Orthop Trauma Surg Hip Arthroplasty INTRODUCTION: Two-stage revision remains the gold standard treatment for most chronically infected and complex total hip arthroplasty infections. To improve patient outcome and reduce complication rates, we have developed a novel custom-made articulating hip spacer technique and present our short-term results. MATERIALS AND METHODS: Between November 2017 and November 2019, 27 patients (mean age 70 years) underwent two-stage revision for periprosthetic joint infection of the hip using the articulating spacer design described here. We retrospectively analyzed spacer-related complications as well as rates for complication, infection control, and implant survivorship after final reimplantation. Furthermore, we prospectively collected patient-reported health-related quality of life (HRQoL) scores prior to spacer implantation, with the spacer and after reimplantation of the new prosthesis. RESULTS: An additional round of spacer exchange was performed in two patients (8.3%), persistent wound discharge was the reason in both cases. We had one (4.2%) spacer-related mechanical complication, a dislocation that was treated with closed reduction. After reimplantation, infection control was achieved in 96% with an implant survivorship of 92% after a mean follow-up time of 19 (range 7–32, SD 7.2) months. While the scores for VR-12 MCS, VAS hip pain and patient-reported overall satisfaction significantly improved after first stage surgery, the scores for WOMAC, UCLA and VR-12 PCS significantly improved after second stage surgery. CONCLUSIONS: Our two-stage approach for periprosthetic joint infection shows high infection eradication and implant survivorship rates at short-term follow-up. Spacer-related complication rates were low, and we achieved high patient satisfaction rates and low pain levels already during the spacer period. To further simplify comparison between different spacer designs, we propose a new hip spacer classification system. Springer Berlin Heidelberg 2021-12-01 2022 /pmc/articles/PMC9596578/ /pubmed/34853867 http://dx.doi.org/10.1007/s00402-021-04274-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Hip Arthroplasty Lunz, Andre Omlor, Georg W. Schmidt, Gunter Moradi, Babak Lehner, Burkhard Streit, Marcus R. Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection |
title | Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection |
title_full | Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection |
title_fullStr | Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection |
title_full_unstemmed | Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection |
title_short | Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection |
title_sort | quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection |
topic | Hip Arthroplasty |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596578/ https://www.ncbi.nlm.nih.gov/pubmed/34853867 http://dx.doi.org/10.1007/s00402-021-04274-4 |
work_keys_str_mv | AT lunzandre qualityoflifeinfectioncontrolandcomplicationratesusinganovelcustommadearticulatinghipspacerduringtwostagerevisionforperiprostheticjointinfection AT omlorgeorgw qualityoflifeinfectioncontrolandcomplicationratesusinganovelcustommadearticulatinghipspacerduringtwostagerevisionforperiprostheticjointinfection AT schmidtgunter qualityoflifeinfectioncontrolandcomplicationratesusinganovelcustommadearticulatinghipspacerduringtwostagerevisionforperiprostheticjointinfection AT moradibabak qualityoflifeinfectioncontrolandcomplicationratesusinganovelcustommadearticulatinghipspacerduringtwostagerevisionforperiprostheticjointinfection AT lehnerburkhard qualityoflifeinfectioncontrolandcomplicationratesusinganovelcustommadearticulatinghipspacerduringtwostagerevisionforperiprostheticjointinfection AT streitmarcusr qualityoflifeinfectioncontrolandcomplicationratesusinganovelcustommadearticulatinghipspacerduringtwostagerevisionforperiprostheticjointinfection |